Services · 01

Commercial Strategy

Winning in pharmaceutical markets is less about promotional intensity and more about commercial clarity. We help pharma and emerging pharma leaders make the foundational decisions that underpin commercial performance: where to compete, which customers to prioritise, and how to build a strategy that holds up when markets shift, competitors respond, and payer dynamics evolve.

What we do

Our Commercial Strategy engagements translate business objectives into actionable commercial plans. Whether you are entering a new market, defending an established brand, managing a portfolio transition, or evaluating a licensing opportunity, we bring structured analytical rigour and deep commercial judgment to the decisions that matter most.

Specific offerings

Brand Positioning & Value Proposition

We develop the clinical and commercial story that earns credibility with HCPs, resonates with payers, and differentiates the brand across its lifecycle. This includes message architecture, stakeholder-specific value narratives, and competitive positioning frameworks.

Market Segmentation & Customer Targeting

Not all prescribers are equal opportunities. We design data-driven segmentation models that identify where commercial investment generates the highest return — building the prioritisation logic that focuses field and marketing resources on the segments most likely to move.

Sales Force Effectiveness (SFE)

We diagnose where reach, frequency, and messaging are losing commercial value — and redesign territory structures, call plans, and engagement models to restore it. Work spans sales force sizing, alignment, call planning, and rep-level performance frameworks.

Incentive Compensation Design

IC plans that reward volume without aligning to strategic behaviour create misaligned field teams. We design and health-check IC frameworks that motivate the right activities, reflect product lifecycle stage, and maintain compliance — with financial modelling to stress-test plan scenarios.

Go-to-Market Planning

We translate brand strategy into an executable commercial plan: defining the channel mix, aligning resource allocation to priority segments, and sequencing milestones with clear ownership. The output is a plan the commercial organisation can actually execute.

Portfolio & Lifecycle Strategy

We help leadership teams make disciplined investment decisions across a product portfolio — prioritising resources where commercial opportunity is strongest, managing brand transitions proactively, and planning for loss of exclusivity before it arrives.

← All services
AI-enabled capability

Predictive segmentation and next-best-action models that continuously reprioritise field engagement based on live prescribing signals, payer coverage changes, and digital engagement patterns — keeping targeting current between planning cycles without manual intervention.

Related case study
Commercial Strategy

Commercial Strategy Redesign for Specialty Brand

Context

A mid-size emerging pharma with an established oncology brand was experiencing declining rep productivity and flat market share despite significant promotional investment. Leadership suspected misaligned targeting but lacked a clear diagnostic.

Approach

We conducted a full SFE assessment — analysing call data, prescribing patterns, and territory alignment against market potential. We redesigned the segmentation model, realigned 180 territories, and rebuilt the call planning logic to concentrate effort on high-potential, under-called accounts.

Outcome

Repositioned field effort generated a measurable uplift in new-to-brand prescribing within two quarters, with no increase in headcount. IC plan redesign, completed in parallel, further reinforced the shift toward strategic account behaviours.

See all case studies →

Tell us the problem

We'll tell you honestly whether and how we can help.

Start a conversation